23andMe Holding Co. – NASDAQ:MEUSW

23andMe Holding stock price today

$1.38

23andMe Holding stock price quarterly change

-55.63%
quarter

23andMe Holding key metrics

Market Cap
N/A
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-1.4
Revenue
219.63M
EBITDA
-84.70M
Income
-666.70M
Revenue Q/Q
-30.68%
Revenue Y/Y
-26.66%
Profit margin
-86.38%
Oper. margin
-134.15%
Gross margin
50.13%
EBIT margin
-134.15%
EBITDA margin
-38.57%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

23andMe Holding stock price history

23andMe Holding stock forecast

23andMe Holding financial statements

23andMe Holding Co. (NASDAQ:MEUSW): Profit margin
Jun 2023 60.86M -104.62M -171.9%
Sep 2023 49.99M -75.27M -150.54%
Dec 2023 44.74M -277.97M -621.22%
Mar 2024 64.02M -208.83M -326.16%
23andMe Holding Co. (NASDAQ:MEUSW): Debt to assets
Jun 2023 871199000 195.70M 22.46%
Sep 2023 801230000 175.97M 21.96%
Dec 2023 608211000 231.02M 37.98%
Mar 2024 395167000 206.64M 52.29%
23andMe Holding Co. (NASDAQ:MEUSW): Cash Flow
Jun 2023 -69.35M -2.69M -114K
Sep 2023 -57.11M -2.77M 1.59M
Dec 2023 -12.06M -2.01M 105K
Mar 2024 -16.99M -2.14M -6.79M

23andMe Holding other data

23andMe Holding Co. (NASDAQ:MEUSW): Insider trades (number of shares)
Period Buy Sel
Sep 2020 475100 0
Oct 2020 100000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BROWN DOUGLAS R
Class A Ordinary Shares 100,000 $10 $1,000,000
Purchase
BROWN DOUGLAS R
Class B Shares in VG Acquisition Holdings LLC 200,000 $5 $1,000,000
Purchase
BAYLISS JOSHUA
Class C Shares in VG Acquisition Sponsor LLC 50 N/A N/A
Purchase
LOCKHART JAMES B. III
Class B Shares in VG Acquisition Holdings LLC 50,000 N/A N/A
Purchase
LOVELL EVAN
Class C Shares in VG Acquisition Sponsor LLC 50 N/A N/A
Purchase
BRIGGS TERESA
Class B Shares in VG Acquisition Holdings LLC 25,000 N/A N/A
Purchase
BROWN DOUGLAS R
Class B Shares in VG Acquisition Holdings LLC 200,000 $5 $1,000,000
  • What's the price of 23andMe Holding stock today?

    One share of 23andMe Holding stock can currently be purchased for approximately $1.38.

  • When is 23andMe Holding's next earnings date?

    Unfortunately, 23andMe Holding's (MEUSW) next earnings date is currently unknown.

  • Does 23andMe Holding pay dividends?

    No, 23andMe Holding does not pay dividends.

  • What is 23andMe Holding's stock symbol?

    23andMe Holding Co. is traded on the NASDAQ under the ticker symbol "MEUSW".

  • What is 23andMe Holding's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of 23andMe Holding?

    Shares of 23andMe Holding can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When 23andMe Holding went public?

    23andMe Holding Co. is publicly traded company for more then 4 years since IPO on 17 Jun 2021.

  • What is 23andMe Holding's official website?

    The official website for 23andMe Holding is 23andme.com.

  • Where are 23andMe Holding's headquarters?

    23andMe Holding is headquartered at 223 N. Mathilda Ave., Sunnyvale, CA.

  • How can i contact 23andMe Holding?

    23andMe Holding's mailing address is 223 N. Mathilda Ave., Sunnyvale, CA and company can be reached via phone at +800 2395230.

23andMe Holding company profile:

23andMe Holding Co.

23andme.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

23andMe, Inc., a consumer genetics and research company, engages in developing a genetic database to unlock insights leading to the rapid discovery of new targets for drug development. It offers a crowdsourced platform that helps people to access, understand, and benefit from the human genome; access direct-to-consumer genetic testing; and give consumers personalized information about their genetic health risks, ancestry, and traits. The company was incorporated in 2006 and is based in Sunnyvale, California with an additional office in Mountain View, California.

223 N. Mathilda Ave.
Sunnyvale, CA 94086

CIK: 0001804591
:
: